TrialPsychopharmacology2014

A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder.

Aurelija Jucaite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.